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Mitochondrial complex I is a large, membrane-bound enzyme central to energymetabolism, and its dysfunction
is implicated in cardiovascular andneurodegenerative diseases. An interesting feature ofmammalian complex I is
the so-called A/D transition, when the idle enzyme spontaneously converts from the active (A) to the de-active,
dormant (D) form. The A/D transition plays an important role in tissue response to ischemia and rate of the con-
version can be a crucial factor determining outcome of ischemia/reperfusion. Here, we describe the effects of
alkali cations on the rate of the D-to-A transition to deﬁnewhether A/D conversion may be regulated by sodium.
At neutral pH (7–7.5) sodium resulted in a clear increase of rates of activation (D-to-A conversion) while other
cations had minor effects. The stimulating effect of sodium in this pH range was not caused by an increase in
ionic strength. EIPA, an inhibitor of Na+/H+ antiporters, decreased the rate of D-to-A conversion and sodium
partially eliminated this effect of EIPA. At higher pH (N8.0), acceleration of the D-to-A conversion by sodium
was abolished, and all tested cations decreased the rate of activation, probably due to the effect of ionic strength.
The implications of this ﬁnding for the mechanism of complex I energy transduction and possible physiological
importance of sodium stimulation of the D-to-A conversion at pathophysiological conditions in vivo are discussed.
© 2015 Published by Elsevier B.V.
1. Introduction
Proton-translocating NADH:ubiquinone oxidoreductase (EC 1.6.5.3,
complex I or Type I NADH dehydrogenase) is themost complex enzyme
of the mitochondrial respiratory chain. Complex I is responsible for the
oxidation of matrix NADH by membrane ubiquinone (Q) and transport
of four protons across the inner membrane, contributing to the proton-
motive force used for ATP generation [1–4]. The enzyme is also thought
to be amajor contributor to the production of reactive oxygen species in
the respiratory chain [5–7]. The atomic structure of the entire complex I
from Thermus thermophilus (16 subunits) suggests a uniquemechanism,
with redox energy of electron transfer driving proton translocation via
long-range conformational changes [3,8]. Mammalian complex I
consists of at least 45 subunits [9], of which more than 30 so-called
“accessory” subunits are not directly involved in catalysis and whose
functions are still unclear. Recently published overall architecture of
mitochondrial complex I [10,11] suggests similar organisation of the
catalytic core and principle of operation via long-range conformational
changes to the prokaryotic enzyme. There are no redox cofactors in
the membrane domain of the enzyme, and transmembrane subunits
involved in the proton translocation are far from the interface with
the hydrophilic domain. The junction between these two domains is a
key area where the redox energy of electron transfer from terminal
cluster N2 to ubiquinone molecule is transduced and transmitted into
the membrane part and used for translocation of protons. Seven
mitochondrial-encoded membrane core subunits form four sets of
putative channels directly involved in proton translocation [10].
In bovine enzyme, three mitochondrially encoded subunits, ND5,
ND4, and ND2 (NuoL, M, and N in prokaryotes), are homologous to
each other [12] and to an Mrp-type Na+/H+ antiporter from Bacillus
halodurans [13] and are often referred to as antiporter-like subunits.
This homology gave rise to the discussion as to whether or not, in ad-
dition to protons, there could also be other ions, namely, sodium,
translocated by mitochondrial complex I in a redox-dependent
manner [14–17].
The catalytic properties of mitochondrial complex I are not simple
(for a review, see [18,19]). Two catalytically and structurally distinct
forms exist in any given preparation of the enzyme: one is the fully com-
petent, so-called active A-form, and the other is the catalytically silent,
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dormant, D-form. Reversible A/D transitions have been described in
mammalian [20] and other eukaryotic complex I [21] and have been
reviewed in detail [19]. After incubation of idle enzyme preparations
at physiological temperatures when catalytic turnover cannot occur,
complex I undergoes deactivation. In the presence of both NADH and
ubiquinone, the D-form is converted back to the A-form as a result
of the slow turnover(s) of the enzyme (ﬁrst-order rate constant,
kD→ A≈ 1min−1). In situ, in conditions of limited oxygen concentration
(i.e., ischemia) all mitochondrial redox components including ubiqui-
none undergo almost complete reduction due to the slowing of cyto-
chrome c oxidase. In such situations, the steady-state equilibrium of
the A↔D transition is shifted to the right. In highly metabolising tissues
such as heart and brain, enzyme readily deactivates in minutes during
ischemia and is reactivated upon reperfusion [22–24].
The exact molecular mechanism causing the hypoxic A/D transition
is unknown. It has been shown that A to D transition involves a confor-
mational change of a mitochondrially encoded subunit ND3. This con-
formational change exposes a critical Cys-39 in the ﬁrst hydrophilic
loop of ND3 and is accompanied by a concerted change in the exposure
of ND1 subunit and nuclear-encoded 39 kDa subunit (NDUFA9)
[25–27]. ND1, ND3, and NDUFA9 subunits are located at the junction
between the hydrophilic and membrane arms of complex I. ND1 and
ND3 are directly involved in the formation of the quinone binding
pocket [3,10].
It is accepted that electron transfer in mitochondrial and bacterial
complex I is coupled with primary translocation of protons [1,2,4,15].
Steuber's group initially reported that complex I from enterobacterium
Klebsiella pneumoniae pumps sodium ions rather than protons [28]. This
claim was later challenged by [29], clearly showing that NADH-
dependent sodium translocation in these experiments was probably
due to contamination of complex I preparations by the sodium-motive
NQR-type enzyme. Despite the publication of redox-dependent sodium
translocation by mitochondrial enzyme [16], no indications suggesting
that complex I functioned as a sodium pump were found [15,30]. In ad-
dition, a potential Na+/H+ antiporter activity was demonstrated for
NADH-oxidase activity of subbacterial particles from Escherichia coli
and Rhodothermus marinus [31,32]. Later, Na+/H+ exchange catalyzed
by the D-form of the bovine enzyme was shown on proteoliposome-
reconstituted enzyme and submitochondrial particles (SMP) [33].
Structural [34–36] and functional studies [17,31,33,37] suggest a
strong possibility of a speciﬁc interaction between complex I and sodi-
um ions affecting the A/D behavior of the enzyme. Putative sodium-
binding sites are located at a long distance from the area of the enzyme
where A/D-dependent change takes place. Taking into account long-
range conformational change during catalytic turnover, the impact of
cation binding at the membrane part of the enzyme on the mobility/
rigidity of subunits involved in A/D transition cannot be excluded.
In addition, slow turnover-dependent A to D conversion might
involve dissociation of bound sodium ions from antiporter-like sub-
units in order for the enzyme to initialize H+-translocation machin-
ery. In situ, at physiological conditions of the mitochondrial matrix,
complex I operates at high osmolarity and ionic strength in the
presence of different cations, such as K+, Na+, which may modulate
the dynamics of the A/D transition.
Thus, it seems plausible to investigate the effect of alkali cations on
the kinetics of the A/D transition of bovine complex I. In the present
study, we demonstrated that alkali cations had aminor effect on the ab-
solute rate of NADH-dependent reactions of the A-form, but signiﬁcant-
ly affected the rate of the D-to-A transition. Unlike other monovalent
cations, sodium showed a stimulating effect on the D-to-A transition,
which was pronounced only at neutral pH. At higher pH, all tested
cations including sodium decelerated the rate of activation.
Whether or not Na+ ions can be translocated bymitochondrial com-
plex I was out of the scope of the presented paper since we focused on
the effect of alkali cations on the kinetics of A/D transition of the
enzyme. Our results provide new information about the mechanism of
A/D transition of mammalian complex I and are aimed to identify the
link between sodium ions and conformational change. This will help
to deﬁne possible modes of ﬁne regulation of the enzyme's activity
during ischemia-reperfusion-associated conditions.
2. Materials and methods
Bovine heart SMP were prepared according to standard proce-
dure [9] and stored in liquid nitrogen.
To prepare SMP in which complex I is in the D-form, SMP were re-
suspended to 5mg/ml in SET buffer pH 8.5 composed of 0.25M sucrose,
0.2mMEDTA, 50mMTris-HCl and incubated at 35 °C for 30–60minutes
under constant shaking. This treatment resulted in almost complete de-
activation of complex I (N90%). To obtain SMP containing the A-form of
the enzyme, suspension of SMP (5 mg/ml) was treated with a NADH
regenerating system as described previously [38]. Alternatively, the en-
zyme was activated by a 10 μM pulse of NADH added directly to the
spectrophotometric cuvette, and then full NADH oxidase or NADH:Q1
oxidoreductase was assayed [38].
The enzymatic activities were assayed at 25 °C spectrophotometri-
cally (Varian Cary 4000) as a decrease in absorption at 340 nm
(ε340nm = 6.22 mM−1 cm−1) with 165 μM NADH in SET medium
containing 10–50 μg of protein/ml SMP. For the measurements of
NADH:Q1 or NADH:HAR oxidoreductase activity, SMP were assayed in
the presence of 1 mM cyanide with the addition of 40 μM Q1 or 1 mM
HAR, respectively. Chloride salts of alkali metals were used in all
experiments. Initially, all alkali metals were tested, but for the sake of
clarity, only results for three cations, i.e., lithium, sodium, and cesium,
are presented.
All chemicals were purchased from Sigma. Protein content was de-
termined with a BCA assay. Reported values are the mean ± SD,
whichwere analyzed by the two-sample t-test to determine statistically
signiﬁcant differences of means among groups (three or more indepen-
dent experiments). The experimental details are described in the
legends to ﬁgures.
3. Results
3.1. The effect of monovalent cations on the NADH-dependent activities of
complex I.
Fig. 1 presents the effects of lithium, sodium, or cesium on various
NADH-dependent catalytic activities of the A-form of complex I from
bovine heart SMP. Resultswith salts of other alkalimetals such as potas-
sium and rubidium were similar (not shown). NADH-oxidase activity
was increased by 30–40% in the presence of 100 mM ions most likely
due to the effect of ionic strength on interactions of complex IV with cy-
tochrome c in SMP (Fig. 1A). As expected, monovalent cations exerted
little effect on NADH:Q1 reductase activity of complex I (Fig. 1B).
HAR is an artiﬁcial electron acceptor that most likely accepts elec-
trons directly from the redox center(s) downstream of the nucleotide
binding site of complex I. This activity is not sensitive to hydrophobic
speciﬁc inhibitors of complex I such as rotenone and it is not dependent
on the A/D state of the enzyme. Therewas a small decline in NADH:HAR
reductase reaction with increasing ionic strength (Fig. 1C).
3.2. Kinetics of activation of the D-form of complex I
As previously shown, the A- and D-forms of the enzyme in SMP
demonstrate different kinetic behavior in physiological NADH-oxidase
or NADH:Q1 reductase reactions [20,39]. In these conditions, when the
reaction was started by SMP containing complex I in the D-form, both
NADH-oxidase and NADH:ubiquinone reductase were catalyzed with
a noticeable lag phase. Duration of the lag phase (i.e., the rate of activa-
tion) was found to be dependent on the presence of monovalent cat-
ions. In Fig. 2, the time course of the NADH-oxidase reaction is shown
1086 A. Stepanova et al. / Biochimica et Biophysica Acta 1847 (2015) 1085–1092
in the presence and absence of 200mM sodium at pH 7.0 and 8.5 (Fig 2,
A and B).
Turnover-dependent activation of complex I duringNADH oxidation
follows ﬁrst-order kinetics [20], and therefore rate constant (kD→ A) can
be derived from the semilogarithmic plots as shown in Fig. 2C. It was
clear that at pH 7.0, addition of sodium signiﬁcantly increased the rate
constant of activation (from 0.93 ± 0.08 to 1.23 ± 0.01 min-1). The op-
posite effect was observed at pH 8.5, when in the presence of sodium
kD → A was decreased (from 0.82 ± 0.06 to 0.64 ± 0.07).
In order to eliminate any pitfalls and artefacts of calculation of ac-
tivation rate constant (due to the possible alteration of the absolute
rate at higher ionic strength or different pH), we determined the
value of kD → A in a wide interval of enzyme concentration. As
shown in Fig. 3, almost seven-fold increase in concentration of the
enzyme in an assay resulted in proportional increase of the NADH-
oxidase reaction rate. However, this did not have any effect on the
constant calculated from the activity traces using semilogarithmic
plots as in Fig. 2B. Therefore, possible variations in the absolute
activity, caused by addition of salts or inhibitors, would not affect
the accuracy of our calculation approach.
The duration of the lag phase in the absence of cations was found
to be pH-independent, indicating no effect of pH on the value of the
kD → A in both NADH:Q1 reductase and NADH-oxidase reactions
when measured in SET buffer (Fig. 4). However, this changed drasti-
cally upon addition of monovalent cations. At neutral pH, only sodi-
um stimulated the rate of the D-to-A transition by 50% and 30%, in
NADH:Q1 reductase and NADH-oxidase reactions, respectively.
At the same time, the opposite effect was observed in more alkaline
medium (Fig. 4). In our initial studies, we found that only near-neutral
pH (b7.5) the nature of the cation had a substantial effect on the
rate constant of activation both in NADH-oxidase and in NADH:Q1
reductase (Fig. 4).
The dependence of apparent rate constant of activation (kD → A) on
concentration of monovalent cations at different pH is shown in Fig. 5.
At neutral pHminor effects of lithium and cesiumon the kD→ Awere ob-
served, while addition of sodium resulted in a clear increase in rates of
activation. At higher pH the stimulating effect of sodiumwas abolished.
Values of apparent afﬁnity of the D-form for alkali ions were deter-
mined from linear reciprocal plot at several pH (Fig. 5). The linear
plots of l/kD → A versus ion concentration were obtained and apparent
dissociation constant (KD) was calculated from the intercepts of the
straight lines with the abscissa [40]. The experimental data shown in
Table 1 conﬁrms that the apparent afﬁnity of the deactivated enzyme
for alkali ions increases as the pH of the assay medium increases. Due
to the apparent stimulation effect of sodium ions at pH b 7.5 (Fig. 5, A
and B), only data for pH interval 8.0–9.0 are shown for this ion (Table 1).
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Fig. 1. The effect of different monovalent cations on NADH-dependent reactions cat-
alyzed by fully active complex I in bovine heart SMP in SET buffer at pH 7.5. Activities
were measured as described under “Materials andMethods” in the presence of differ-
ent concentrations of lithium (○), sodium (Δ), and cesium (■). A, NADH-oxidase, B,
NADH:Q1 oxidoreductase, C, NADH:HAR oxidoreductase. Values are given in μmol
NADH × min−1 × mg−1.
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Fig. 2. Effect of sodium on kinetics of the NADH-oxidase reaction catalyzed by the D-form of complex I from bovine SMP. Representative traces of NADH oxidation by SMP containing only
the D-form of complex I. The reaction was initiated by addition of SMP (17.5 μg/ml) to 1 ml of SET buffer pH 7.0 (A) and 8.5 (B) containing 150 μMNADH in the absence (1, 2) and in the
presence (3, 4) of 200 mM sodium. (C) Determination of the ﬁrst-order rate constant of activation (kD → A) in the NADH-oxidase reaction catalyzed by the D-form of the enzyme. Linear
transformation traces from the A and B: trace 1 pH 7, no sodium (●), trace 2 pH 7.0, 200 mM sodium (Δ), trace 3, pH 8.5, no sodium (□), trace 4, pH 8.5, 200 mM sodium (∇).
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Rate constant for complex I activation (kD → A) in the presence
of 200 mM monovalent cations also depends strongly on pH of the
medium in the interval of 7.0–9.0 (Fig. 5 and Table 1).
In our experiments, the duration of the lag phase seen in the absence
of any cations was found to be pH-independent (Fig. 4). However, our
ﬁnding contradicts earlier data [40,41], inwhich activation rate constant
was found to be much slower at the alkaline pH. We tested pH depen-
dence of the D-to-A conversion using the exact assay conditions as in
the original paper [40] (0.25 M sucrose, 50 mM HEPES, 0.1 mM EDTA,
5 mMmalonate, 1 mg/ml BSA for SMP deactivation and 0.25M sucrose,
0.1mMEDTA, 0.1 μMFCCP for measurements). The apparent rate of ac-
tivation in this condition was not found to be affected by alkalization of
the measuring medium (4.7 min−1 at the pH interval from 7.0–9.0).
Next, we examined the effect of sodium on D-to-A transition at dif-
ferent pH using a combined system of Na+/Li+ or Na+/Cs+, changing
concentrations of both ions while keeping total ionic strength constant
(200mM). If the stimulating effect of sodium (Fig. 5A)was independent
of ionic strength, then in the system where total concentration of both
cations [Na++M+] is kept constant, the increase in sodium content
should correlate with increase in kD → A values only at pH b 7. As
shown in Fig. 6, an increase in the concentration of sodium in the
presence of another alkali ion resulted in stimulation of D-to-A change,
i.e., increase in the values of apparent kD → A rate constant. This effect
was only observed at pH 7 and disappeared at more alkaline pH N 8.0.
Data presented at Figs. 5 and 6may be explained by two opposite ef-
fects of the cations at different pH. At pH b 7.5, sodium increased the
rate of D-to-A conformational change, and this phenomenon disap-
peared with the increase in pH. (Fig. 5, A and B). At more alkaline pH,
all tested cations decreased the rate of activation, due to the effect of
ionic strength clearly evident at pH N 8.0.
3.3. Effect of EIPA on activation of the D-form of complex I.
It has been shown that the function of complex I can be affected by
inhibitors of Na+/H+ antiporters such as EIPA [32,37,42]. The effective-
ness of the inhibitor towards Na+/H+ exchanger increases with
decreasing in sodium concentration, providing evidence for a shared
binding site for amiloride and sodium [43,44]. Therefore, it was of inter-
est to study the effect of EIPA on the D-to-A transition in the presence
and absence of sodium in the conditions where this cation showed a
stimulating effect. The inhibitory effect of EIPA on NADH:Q1 activity of
bovine complex I was found to be strongly pH-dependent with IC50
decreased around ﬁve-fold at the pH interval from 7.0–8.0 (Fig. 7).
Since the stimulating effect of sodium was observed only at neutral
pH, we tested the effect of EIPA on complex I at pH 7.0. Addition of
EIPA affected the activity of the enzyme and decreased the rate of
D-to-A conversion (Fig. 8, A and B). Addition of sodium partially
abolished the inhibitory effect of EIPA on the D-to-A transition (Fig. 8,
A and B), but had very little effect on the activity (Fig. 8B). Inhibitory
potency of EIPA was exactly the same in the presence and the absence
of sodium (not shown). Interestingly, both sodium and lithium
decreased the inhibitory effect of EIPA on the D-to-A transition, but
other cations including cesium did not show a protective effect
(Fig. 8C). At pH 7.0 the 20 μM EIPA lowered kD → A from 1.00 ±
0.04 to 0.22 ± 0.04 min−1 in the absence of alkali cations, and
addition of sodium or lithium increased the value for EIPA-treated
enzyme about two-fold (Fig. 8C).
4. Discussion
Alkalimetal ions are present in high concentrations in themitochon-
dria, such that estimated ionic strength in the matrix is equivalent to
150 mM KCl [45,46]. Therefore, it is reasonable to assume that alkali
cationsmay be involved inmodulation of enzymatic function. Similarity
of subunits ND5, ND4, andND2 toNa+/H+, antiporter and experimental
data available to date [31,33,34,36,37] indicate that sodium might
be binding speciﬁcally to mitochondrial complex I, thus affecting its
catalytic behavior.
In our initial studies, we observed veryminor effects of alkali cations
on NADH-dependent activities of mitochondrial complex I in bovine
SMP at pH 7.5. Only a minor increase in NADH-oxidase reaction was
found, most likely indicating activation of the cytochrome c oxidase in
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Fig. 3. Dependence of activation rate constant (kD → A) and rate of the NADH-oxidase re-
action on the amount of the enzyme present in the assay (pH7.5). Activation rate constant
(●) was determined as in Fig. 2B. Reaction was initiated by addition of SMP containing
complex I in the D-form to a standard assay supplemented with 150 μM NADH and ﬁnal
rate of the NADH-oxidase reaction was assessed after full activation of the enzyme (□).
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Fig. 4. The pH-dependence of the rate constant of activation (kD → A) of the enzyme in
NADH:Q1 reductase (A) and NADH-oxidase (B) reaction in the absence (●) or presence
of 200 mM lithium (○), sodium (Δ) and caesium (■).
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inside-out SMP at higher ionic strength [47,48]. Unlike in prokaryotic
enzyme [49,50], NADH:ubiquinone reductase activity of bovine com-
plex I in SMP in neutral medium was not affected by ionic strength up
to 200 mM salt.
It has been shown that activation of the enzyme (D-to-A transition)
involves subunits ND3, ND1, and most likely 39 kDa [27] and, based on
the crystal structure, subunit 49 kDa (NDUFS2). Slow concerted move-
ment of their loops results in formation of the quinone binding site in
the A-form and could also reﬂect a critical energy-transducing step
during steady-state catalytic turnover. Our observations support this
hypothesis. Steady-state NADH:ubiquinone reductase activity of the
enzyme has a very broad pH optimum [19], and in our experiments,
the duration of the lag phase seen in the absence of any cations was
also found to be pH-independent. This observation contradicts earlier
ﬁnding from Vinogradov's group [40]. A possible explanation for this
discrepancymight be the different lipid composition of SMPmembrane
from each author’s lab due to the young age of cattle used as well as
seasonal variations [51,52]. It is known that membrane fatty acids affect
the dynamics of A/D transition in a pH-dependent manner [53].
We show that alkali cations have strong and pH-dependent effects
on the kinetics of the conformational A/D transition of the bovine
complex I. We observed that at pH N 7.5 all tested alkali metal cations
decelerate the rate of D-to-A conversion; however, this inhibitory effect
is probably unspeciﬁc. It has been well recognized that membrane
surface charge density is an important factor in many of the functions
of biological membrane systems. We suggest that at higher pH the
deprotonation of membrane lipids or negatively charged TMH5 loop
of ND1 results in more effective interactions with cations, and therefore
shielding favorable electrostatic interactions involved in D-to-A confor-
mational change [11].
While none of the cations tested have effects on activation of the D
form in alkaline conditions, at neutral pH, only sodium ions show a
stimulating effect. This was due to the speciﬁc effect of increase in
sodium concentration and not due to the increase of total ionic strength
of the medium. Control experiments were carried out in which part of
the sodiumwas substituted by either lithium or cesiumwithout chang-
ing the total ionic strength of the medium. This substitution decreased
the rate of the D-to-A transition, and the stimulating effect of sodium
was abolished. Conversely, increasing the sodium content in the
combined system signiﬁcantly accelerates the D-to-A transition.
It is also possible that the observed effect is related to the afﬁnity of
ions to the putative binding site at the antiporter-like subunits of the
enzyme. Stimulatory effect of sodium in the combined system reﬂects
higher afﬁnity of the binding site(s) to sodium and therefore elevated
occupancy of the enzyme by this ion at neutral pH.
Therefore, we conclude that there are two opposite effects of the
cations. One is a sodium-speciﬁc stimulation of the enzyme D→ A tran-
sition (increase in kD→ A value) occurring at neutral pH; and the other is
unspeciﬁc deceleration of D-to-A conversion by ionic strength observed
for all cations atmore alkaline pH (N7.5). Even if sodium-speciﬁc activa-
tion takes place at alkaline pH, this would be masked by the inhibitory
effect of ionic strength.
Although we found that variation in both pH and ionic strength are
important factors in the process of the D-to-A conformational change
of mitochondrial complex I, quantitatively assessing their role inmodu-
lating electrostatic energies is challenging [54]. Our results suggest that
interaction of membrane subunits with lipid molecules is an important
factor determining the dynamics of A/D conversion. It is in conjunction
with our previous identiﬁcation of two membrane subunits ND3 and
ND1 found to be directly involved into A/D transition [26]. Subunit
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Fig. 5.Dependence of the apparent rate constant of activation (kD→ A) in theNADH:Q1 reductase reaction on concentration of lithium (○), sodium (Δ), and cesium(■) at pH 7, 7.5, 8.5, and
9.0 (A, B, C, and D, respectively). Dependence of kD → A at low concentration of sodium at pH 7.0 and 7.5 are shown at the insets to A and B.
Table 1
pH-dependence of the apparent activation rate constant of D-to-A transition (kD→ A) inNADH:Q1 oxidoreductase reaction and the apparent dissociation constant of theD-formand cation.
pH kD → A, min−1 a KD, mM b
control Li+ Na+ Cs+ Li+ Na+ Cs+
7.0 1.24 ± 0.06 1.04 ± 0.10 1.76 ± 0.28 1.28 ± 0.12 723 ± 149 n.d. 601 ± 202
7.5 1.21 ± 0.22 0.85 ± 0.03 1.25 ± 0.09 0.83 ± 0.08 184 ± 62 n.d. 141 ± 41
8.0 1.13 ± 0.16 0.75 ± 0.12 0.95 ± 0.10 0.62 ± 0.07 201 ± 42 246 ± 65 168 ± 21
8.5 1.17 ± 0.18 0.51 ± 0.09 0.56 ± 0.06 0.36 ± 0.04 83 ± 5 137 ± 16 71 ± 5
9.0 1.15 ± 0.11 0.31 ± 0.05 0.31 ± 0.03 0.24 ± 0.05 85 ± 7 90 ± 9 45 ± 7
a Measured at 200 mM concentration of monovalent cation.
b Determined from the abscissa intercepts in Fig. 5
1089A. Stepanova et al. / Biochimica et Biophysica Acta 1847 (2015) 1085–1092
39 kDa (NDUFA9) [25,27] is also associated with this conformational
change and it was thought to be anchored to the membrane [55,56].
Although recent structural studies did not show any transmembrane
helices in this subunit, it is in fact located very close to the membrane
surface [10].
Another important observation is the speciﬁc effect of sodium on
the process of A/D transition of the enzyme. As mentioned before, the
structural rearrangements during de-activation of complex I include
subunits located at the junction between hydrophilic and hydrophobic
domains, in the region of the quinone binding site. Three antiporter-
like membrane subunits ND5, ND4, and ND2 are located at signiﬁcant
distance from the site of these changes [3,10]. Therefore, the question
of how potential binding of sodium ion(s) would affect the mobility/
rigidity of the subunits near the Q-binding site is an open one. During
catalytic turnover, redox energy of electron transfer released at the
quinone-binding site should be somehow transduced and delivered to
membrane part. Taking into account reversibility of the NADH:quinone
oxidoreductase reaction, it is reasonable to expect a possibility of long-
distance transmission of a change within distal membrane subunits
towards the hydrophilic domain. Consequently, binding of sodium at
the distal antiporter-like subunit(s) can potentially inﬂuence dynamics
of the entire couplingmachinery including area of quinone-binding site,
therefore affecting the process of A/D transition. It was suggested that
long transverse helix HL of ND5, a proposed coupling element of proton
translocation, coordinates conformational changes by linking discontin-
uous transmembrane helices between the ND5, ND4, and ND2 [57,58].
Whether or not activation of the enzyme during catalytic turnover is as-
sociated with energy-dependent ion translocation is still unclear. At the
same time, although we did not observe any inﬂuence of monovalent
cations on absolute NADH:ubiquinone activity of the enzyme, a direct
effect of ions on the process of ubiquinone binding to the enzyme
cannot be excluded.
Our data obtained from EIPA-inhibited enzyme conﬁrmed sodium-
speciﬁcity of this stimulating effect. At neutral pH, EIPA is a relatively
weak inhibitor of NADH:Q1 oxidoreductase activity of the bovine
enzyme (IC50 ~ 40 μM) and also decelerates D-to-A transition. Addition
of sodium abates the inhibitory effect of EIPA. Taking into account that
the guanidinium group of amiloride and a hydrated sodium ion are
of similar size and shape [59], binding sites of sodium and EIPA in
Na+/H+ antiporter molecule may overlap [43,44]. Therefore, it is not
surprising that in the presence of sodium (or lithium), the inhibitory
effect of EIPA on the D-to-A transition was decreased. However, there
is no direct evidence that amilorides inhibitors (i.e. EIPA) bind to
antiporter-like subunits of complex I. The initial publication showing
that amilorides protect ND5 subunits from covalent labeling by
fenpyroximate [60] was later challenged byMiyoshi group [61]. Indeed,
recently it has been demonstrated that amiloride derivatives bind in the
quinone pocket of bovine complex near subunit 49 kDa [62].
The A/D transition of complex I may be considered a critical event in
determining the outcome of ischemia/reperfusion [22,63,64]. In animal
models, diminution of complex I activity during reoxygenation would
protect mitochondria from irreversible damage [63,65–68] most likely
via a decrease in oxidative stress [63,68,69]. Relatively slow activation
of the D-form (during D-to-A transition) upon tissue reoxygenation
may therefore serve as a protective valve and reduce the burst of
respiration and consequently ROS production at the level of complex I
or downstream sites. Therefore, the outcome of the reperfusion
can be signiﬁcantly inﬂuenced by the rate of activation of the
D-form of the enzyme. As the cellular ionic balance changes dra-
matically during ischemia/reperfusion (see [70] for review), the
signiﬁcant rise in cytoplasmic sodium [70,71] changes sodium
0 50 100 150 200
+
0 50 100 150 200
+
200 150 100 50 0
+
200 150 100 50 0
+
0.5
1.0
1.5
2.0
A
→
D
-
1
0.5
1.0
1.5
2.0
A
→
D
-
1
BA
Fig. 6. Values of apparent activation rate constant (kD → A) in the NADH:Q1 reductase reaction in the presence of different concentrations of sodium at pH 7.0 and 9.0 (open and closed
circles respectively). Total ionic strength of the mediumwas kept constant using a combination of sodium with either lithium (A) or caesium (B) ions.
6.5 7.0 7.5 8.0 8.5 9.0
0
15
30
45
60
IC
50
,
µM
pH
Fig. 7. pH dependence of IC50 for EIPA in NADH-oxidase reaction of SMP containing the
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entry to mitochondria. Consequently, it would affect activation of
complex I upon oxygen deprivation and reperfusion [72,73]. The effect
of sodium on A/D transition, which is discussed here, might inﬂuence
the rate of the D-to-A conversion of the mitochondrial complex I in
pathological scenarios, providing another important mechanism for
ﬁne tuning of the activity of this enzyme.
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